DBV Technologies S.A. - DBVT
About Gravity Analytica
Recent News
- 07.14.2026 - DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026
- 07.14.2026 - DBV Technologies présente ses résultats financiers du premier semestre 2026 et fait le point sur ses activités le 16 julliet 2026
- 07.06.2026 - Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
- 07.06.2026 - Bilan semestriel du Contrat de Liquidité de DBV Technologies avec ODDO BHF
- 06.29.2026 - DBV Technologies fait le point sur le dépôt du dossier BLA pour le patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans; la Société travaille en collaboration avec la FDA afin d'optimiser le processus d'examen en vue du dépôt du dossier
- 06.29.2026 - DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing
- 06.23.2026 - DBV Technologies Announces Inclusion in the Euronext Tech Leaders Index
- 06.23.2026 - DBV Technologies intégrera l’Indice Euronext Tech Leaders
- 06.09.2026 - DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference
- 06.09.2026 - DBV Technologies révise sa participation à la 47ème conférence annuelle Global Healthcare organisée par Goldman Sachs
Recent Filings
- 06.29.2026 - 8-K Current report
- 06.29.2026 - EX-99.1 EX-99.1
- 06.05.2026 - 8-K Current report
- 06.04.2026 - S-8 Securities to be offered to employees in employee benefit plans
- 06.03.2026 - 8-K Current report
- 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 05.13.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 05.13.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 05.12.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 05.11.2026 - ARS Annual Report to Security Holders